Shah Sujal - Insider Non-Derivative Transactions at CymaBay Therapeutics, Inc. (CBAY) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 22, 2024, Shah Sujal's relationship to CymaBay Therapeutics, Inc. (CBAY) is Director,Officer (Chief Executive Officer), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CBAY insiders.

Data Source: SEC.
Shah Sujal - Insider Non-Derivative Transactions of CBAY Common Stock
Shah Sujal - Insider Non-Derivative Transactions at CBAY
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 23, 2024 Disposition -- (Common Stock) 310420 0 0
Mar 23, 2024 Disposition -- (Common Stock) 96250 0 0
Mar 14, 2024 M -- (Common Stock) 11649 10 279200
Mar 14, 2024 M -- (Common Stock) 14625 1.06 293825
Mar 14, 2024 M -- (Common Stock) 52084 1.72 345909
Mar 14, 2024 M -- (Common Stock) 18899 9.21 364808
Mar 14, 2024 M -- (Common Stock) 3125 11.69 367933
Mar 14, 2024 M -- (Common Stock) 14372 8.43 382305
Mar 14, 2024 M -- (Common Stock) 22076 4.05 404381
Mar 14, 2024 M -- (Common Stock) 2288 5.78 406669
Mar 14, 2024 M -- (Common Stock) 1 2.94 406670
Jan 25, 2024 Acquisition -- (Common Stock) 96250 0 267551
Dec 12, 2023 Sell -- (Common Stock) 890 20.81 171301
Dec 12, 2023 Sell -- (Common Stock) 63975 19.99 171301
Dec 12, 2023 M -- (Common Stock) 890 5 172191
Dec 12, 2023 M -- (Common Stock) 63975 5 235276
Nov 14, 2023 Sell -- (Common Stock) 44008 15.89 171301
Nov 14, 2023 Sell -- (Common Stock) 20855 15.89 171301
Nov 14, 2023 M -- (Common Stock) 20855 5 192156
Nov 14, 2023 M -- (Common Stock) 44008 5 215309
Oct 10, 2023 Sell -- (Common Stock) 64861 14.2 171301
Oct 10, 2023 M -- (Common Stock) 64861 5 236162